Dean et al. found that IGFBP2 can be used to indicate the PI3K/AKT pathway activation and PTEN status, and participates in the carcinogens of many types of cancer through the cascade with PTEN.57, 58, 59, 60. Here, IGFBP2 is linked to cancer.